Recent Press Releases

Corium Announces Publication of Promising Data for Needle-Free Transdermal Influenza Vaccine

MENLO PARK, Calif., May 18, 2015 (GLOBE NEWSWIRE via COMTEX) -- Corium International, Inc. CORI, +7.04% a commercial-stage biopharmaceutical company focused on the development, manufacture and...

Daiichi Sankyo Announces Cooperative Sales Agreement for the Influenza HA Vaccine "Kaketsuken"

Tokyo, Japan (May 19, 2015) – Daiichi Sankyo Company, Limited (hereinafter, Daiichi Sankyo) today announced that it has signed a cooperative sales agreement (hereinafter, The Agreement) with...

Takeda Announces Seasonal Influenza Vaccine Sales Agreement with Kaketsuken in Japan

Osaka, Japan, May 19, 2015 – Takeda Pharmaceutical Company Limited ("Takeda") today announced that it has entered into an agreement with the Chemo-Sero-Therapeutic Research Institute (Head...

VaxInnate Enhances R&D Program and Strengthens Senior Management Team to Drive Pipeline Development of Current and Potential Targets

Lynda Tussey, PhD, Promoted to Chief Scientific Officer; Senior Appointments and Promotions Announced in R&D, Clinical and Manufacturing Cranbury, NJ, May 13, 2015 (GLOBE NEWSWIRE) -- VaxInnate...

Oxford University, GSK, and Emergent BioSolutions Announce Initiation of a Prime Boost Study of Ebola Vaccine Candidates

OXFORD, U.K., LONDON and GAITHERSBURG, Md., May 13, 2015 (GLOBE NEWSWIRE) -- A new phase 1 study has begun at the University of Oxford that will investigate the use of a modified vaccinia Ankara...

PaxVax Appoints Nima Farzan Chief Executive Officer

May 11, 2015 07:45 AM Eastern Daylight Time REDWOOD CITY, Calif.--(BUSINESS WIRE)--PaxVax, Inc., a specialty vaccine company focused on travel and biodefense, today announced that the Board of...

Bavarian Nordic Announces Positive Results from Two Pivotal Clinical Studies of IMVAMUNE® Smallpox Vaccine

• Completion of first Phase 3 study to support a Biologics License Application for liquid-frozen IMVAMUNE • Completion of clinical development to support stockpiling of the next-generation...

First-of-its-kind West Nile virus vaccine now in Phase I clinical trials

PORTLAND, Ore., May 7, 2015 /PRNewswire/ -- A novel investigational West Nile virus vaccine discovered and developed by scientists at the Oregon National Primate Research Center at Oregon Health...

Turnstone Biologics Inc. to accelerate clinical and commercial translation of cancer immunotherapies

TORONTO, May 4, 2015 /PRNewswire/ - The Fight Against Cancer Innovation Trust (FACIT) and its partners are pleased to announce the formation of Turnstone Biologics Inc. (Turnstone), a biotechnology...

Agenus Vaccine Shows Significant Reduction in Viral Burden After HerpV Generated Immune Activation

Lexington, MA – June 26, 2014 Agenus Inc. (Nasdaq: AGEN), an immuno-oncology company developing a portfolio of checkpoint modulators (CPMs), heat shock protein peptide-based vaccines, and...

Genocea Presents Complete Phase 1/2a Data for HSV-2 Immunotherapy at IDWeek

After 12 months, GEN-003 shows durable reduction in genital lesions CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing T...

Genocea's GEN-003 in Prime Position to Lead Genital Herpes Vaccine Space, says GlobalData Analyst

LONDON, UK (GlobalData), 28 April 2015 - Genocea Biosciences' investigational genital herpes (GH) vaccine, GEN-003, is better positioned to compete in the future GH treatment space, despite being...

Themis Bioscience's Raises up to EUR 10 Million in Series B

New Board to drive partnerships and commercialization of product pipeline Vienna (Austria), 5 May 2015 - Themis Bioscience ('Themis'), a biotechnology company developing innovative...

New Company to Develop Vaccines, Discovered by City of Hope Researchers, to Protect Against CMV Infections in Cancer Patients

DUARTE, Calif.--(BUSINESS WIRE)--City of Hope and Fortress Biotech have reached an agreement to form a new subsidiary company, DiaVax Biosciences, that will develop two novel vaccines against...

Amgen statement on T-Vec Advisory Committee meeting

Metastatic melanoma continues to be a major challenge to patients and caregivers. It is a complex and heterogeneous disease that often requires the use of multiple treatment modalities. Despite...

The Lancet: Scientists announce final trial results of the world's most advanced malaria vaccine

The first malaria vaccine candidate (RTS,S/AS01) to reach phase 3 clinical testing is partially effective against clinical disease in young African children up to 4 years after vaccination, according...

GSK response to MSF vaccines report

More children from the world's poorest countries are being vaccinated against more diseases than ever before. This is a good thing and has been made possible by unprecedented cooperation between...

Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results

BEIJING, April 20, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products inChina, today announced its unaudited financial results for the fourth...

Vical to Manufacture HIV Vaccines for Clinical Evaluation by Public-Private Partnership Initiative

Vical to receive $4 million under new contract with IPPOX Foundation, funded via a grant from the Bill & Melinda Gates Foundation, to supply plasmid DNA for HIV vaccine clinical trials Builds...

PaxVax Announces Global Expansion of Commercial Network for Its Typhoid Vaccine Vivotif

REDWOOD CITY, Calif.--(BUSINESS WIRE)--PaxVax, Inc., a specialty vaccine company focused on travel and biodefense, today announced a series of new commercial partnerships and distribution agreements...